Spironolactone Tablet, Film Coated
Product Images NDC 0904-6927

4 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 0904-6927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure diagram of spironolactone, showing its molecular framework with multiple rings and functional groups including ketones and a thioester group.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival curve comparing probability over time (months) between patients treated with spironolactone (n=822) and those given placebo (n=841). The graph shows higher survival probability for spironolactone over 42 months, with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot depicting hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone to placebo. Subgroups include age, sex, race, LVEF, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin, ACEI, and beta blocker use. The horizontal axis shows effect size with spironolactone favoring the left and placebo favoring the right.*
FDA Label Image

25mg Carton Label (79b8df9c 5a73 432e Bd16 Bbbecd9e2046 00)

25mg Carton Label (79b8df9c 5a73 432e Bd16 Bbbecd9e2046 00)
Label for spironolactone 25 mg film coated tablets by Major Pharmaceuticals, NDC 0904-6927-61. The package contains 100 tablets (10 x 10), labeled as Unit Dose and Rx only. The label includes dosing information, storage instructions, safety warnings, and distributor details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.